Paloma Partners Management CO Amicus Therapeutics, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $89,148 - $120,768	-10,200 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $88,842 - $109,344	10,200 New	10,200 $98,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $1.89 Million - $3.49 Million	-140,133 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $1.81 Million - $2.23 Million	140,133 New	140,133 $1.98 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $448,718 - $755,308	-67,680 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $506,246 - $727,560	67,680 New	67,680 $659,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.